BNT162b2 versus mRNA-1273 mRNA COVID-19 vaccines as the third booster for the patients with underlying cancer

Saved in:
Bibliographic Details
Main Authors: Amnuay Kleebayoon, Viroj Wiwanitkit
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2023-12-01
Series:The Journal of Association of Chest Physicians
Online Access:https://journals.lww.com/10.4103/jacp.jacp_31_23
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832593946488864768
author Amnuay Kleebayoon
Viroj Wiwanitkit
author_facet Amnuay Kleebayoon
Viroj Wiwanitkit
author_sort Amnuay Kleebayoon
collection DOAJ
format Article
id doaj-art-966f47c90b234486a35403a77364a4a3
institution Kabale University
issn 2320-8775
language English
publishDate 2023-12-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series The Journal of Association of Chest Physicians
spelling doaj-art-966f47c90b234486a35403a77364a4a32025-01-20T07:28:01ZengWolters Kluwer Medknow PublicationsThe Journal of Association of Chest Physicians2320-87752023-12-0111424324310.4103/jacp.jacp_31_23BNT162b2 versus mRNA-1273 mRNA COVID-19 vaccines as the third booster for the patients with underlying cancerAmnuay KleebayoonViroj Wiwanitkithttps://journals.lww.com/10.4103/jacp.jacp_31_23
spellingShingle Amnuay Kleebayoon
Viroj Wiwanitkit
BNT162b2 versus mRNA-1273 mRNA COVID-19 vaccines as the third booster for the patients with underlying cancer
The Journal of Association of Chest Physicians
title BNT162b2 versus mRNA-1273 mRNA COVID-19 vaccines as the third booster for the patients with underlying cancer
title_full BNT162b2 versus mRNA-1273 mRNA COVID-19 vaccines as the third booster for the patients with underlying cancer
title_fullStr BNT162b2 versus mRNA-1273 mRNA COVID-19 vaccines as the third booster for the patients with underlying cancer
title_full_unstemmed BNT162b2 versus mRNA-1273 mRNA COVID-19 vaccines as the third booster for the patients with underlying cancer
title_short BNT162b2 versus mRNA-1273 mRNA COVID-19 vaccines as the third booster for the patients with underlying cancer
title_sort bnt162b2 versus mrna 1273 mrna covid 19 vaccines as the third booster for the patients with underlying cancer
url https://journals.lww.com/10.4103/jacp.jacp_31_23
work_keys_str_mv AT amnuaykleebayoon bnt162b2versusmrna1273mrnacovid19vaccinesasthethirdboosterforthepatientswithunderlyingcancer
AT virojwiwanitkit bnt162b2versusmrna1273mrnacovid19vaccinesasthethirdboosterforthepatientswithunderlyingcancer